These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27469509)

  • 1. A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model.
    Wang F; Travins J; Lin Z; Si Y; Chen Y; Powe J; Murray S; Zhu D; Artin E; Gross S; Santiago S; Steadman M; Kernytsky A; Straley K; Lu C; Pop A; Struys EA; Jansen EE; Salomons GS; David MD; Quivoron C; Penard-Lacronique V; Regan KS; Liu W; Dang L; Yang H; Silverman L; Agresta S; Dorsch M; Biller S; Yen K; Cang Y; Su SM; Jin S
    J Inherit Metab Dis; 2016 Nov; 39(6):807-820. PubMed ID: 27469509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice.
    Akbay EA; Moslehi J; Christensen CL; Saha S; Tchaicha JH; Ramkissoon SH; Stewart KM; Carretero J; Kikuchi E; Zhang H; Cohoon TJ; Murray S; Liu W; Uno K; Fisch S; Jones K; Gurumurthy S; Gliser C; Choe S; Keenan M; Son J; Stanley I; Losman JA; Padera R; Bronson RT; Asara JM; Abdel-Wahab O; Amrein PC; Fathi AT; Danial NN; Kimmelman AC; Kung AL; Ligon KL; Yen KE; Kaelin WG; Bardeesy N; Wong KK
    Genes Dev; 2014 Mar; 28(5):479-90. PubMed ID: 24589777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation.
    Geoerger B; Schiff M; Penard-Lacronique V; Darin N; Saad SM; Duchon C; Lamazière A; Desmons A; Pontoizeau C; Berlanga P; Ducassou S; Yen K; Su M; Schenkein D; Ottolenghi C; De Botton S
    Nat Med; 2023 Jun; 29(6):1358-1363. PubMed ID: 37248298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.
    Kranendijk M; Struys EA; van Schaftingen E; Gibson KM; Kanhai WA; van der Knaap MS; Amiel J; Buist NR; Das AM; de Klerk JB; Feigenbaum AS; Grange DK; Hofstede FC; Holme E; Kirk EP; Korman SH; Morava E; Morris A; Smeitink J; Sukhai RN; Vallance H; Jakobs C; Salomons GS
    Science; 2010 Oct; 330(6002):336. PubMed ID: 20847235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: novel avenues for biochemical and therapeutic studies.
    Kranendijk M; Salomons GS; Gibson KM; Van Schaftingen E; Jakobs C; Struys EA
    Biochim Biophys Acta; 2011 Nov; 1812(11):1380-4. PubMed ID: 21889589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia and dilated cardiomyopathy in a pediatric patient with D-2-hydroxyglutaric aciduria type I.
    Murphey K; George PE; Pencheva B; Porter CC; Wechsler SB; Gambello MJ; Li H
    Am J Med Genet A; 2022 Sep; 188(9):2707-2711. PubMed ID: 35785415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cases of D-2-hydroxyglutaric aciduria with IDH1 or IDH2 mosaic mutations identified by amplicon deep sequencing.
    Nota B; Hamilton EM; Sie D; Ozturk S; van Dooren SJ; Ojeda MR; Jakobs C; Christensen E; Kirk EP; Sykut-Cegielska J; Lund AM; van der Knaap MS; Salomons GS
    J Med Genet; 2013 Nov; 50(11):754-9. PubMed ID: 24049096
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Srinivasan A; Zhou Y; Scordino T; Prabhu S; Wierenga A; Simon G; Wierenga KJ; Thompson J; Shah R; Sinha AA
    Pediatr Hematol Oncol; 2020 Aug; 37(5):431-437. PubMed ID: 32166993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.
    Thirumal Kumar D; Jerushah Emerald L; George Priya Doss C; Sneha P; Siva R; Charles Emmanuel Jebaraj W; Zayed H
    Metab Brain Dis; 2018 Oct; 33(5):1699-1710. PubMed ID: 29987523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
    Li L; Paz AC; Wilky BA; Johnson B; Galoian K; Rosenberg A; Hu G; Tinoco G; Bodamer O; Trent JC
    PLoS One; 2015; 10(9):e0133813. PubMed ID: 26368816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A
    Li H; Hurlburt AJ; Tennessen JM
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity.
    Xie X; Baird D; Bowen K; Capka V; Chen J; Chenail G; Cho Y; Dooley J; Farsidjani A; Fortin P; Kohls D; Kulathila R; Lin F; McKay D; Rodrigues L; Sage D; Touré BB; van der Plas S; Wright K; Xu M; Yin H; Levell J; Pagliarini RA
    Structure; 2017 Mar; 25(3):506-513. PubMed ID: 28132785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enasidenib-induced hepatitis in an individual with Type II D2-hydroxyglutaric aciduria.
    Gold JI; Stefanatos AK; Fraser JL; Vanderver A; Cuddapah S
    JIMD Rep; 2024 May; 65(3):156-162. PubMed ID: 38736636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-2-hydroxyglutaric aciduria. Report of two cases].
    Mahfoud A; Domínguez CL; Rashed M; Durán M; Rodríguez T; Rodríguez D; Landa V
    Invest Clin; 2009 Sep; 50(3):369-75. PubMed ID: 19961059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndromes and malignant transformation: where the twain shall meet.
    Bhagwat N; Levine RL
    Sci Transl Med; 2010 Oct; 2(54):54ps50. PubMed ID: 20962328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy in a patient with D-2-hydroxyglutaric aciduria.
    Haliloglu G; Temucin CM; Oguz KK; Celiker A; Coskun T; Sass JO; Fischer J; Topcu M
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S21-5. PubMed ID: 19169842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
    Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
    J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm.
    Rakheja D; Fuda F; Vandergriff T; Boriack R; Medeiros BC; Frankel AE; Chen W
    Hum Pathol; 2015 Feb; 46(2):322-6. PubMed ID: 25481493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-2-hydroxyglutaric aciduria caused by a new mutation in the L2HGDH gene].
    Saifullina EV; Zakharova EY; Kurkina MV; Magzhanov RV; Gaisina EV; Zakirova EN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4):81-85. PubMed ID: 28617386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feedback loop engaging propionate catabolism intermediates controls mitochondrial morphology.
    Zhou J; Duan M; Wang X; Zhang F; Zhou H; Ma T; Yin Q; Zhang J; Tian F; Wang G; Yang C
    Nat Cell Biol; 2022 Apr; 24(4):526-537. PubMed ID: 35418624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.